Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HSD17B7 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | TAF8 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | C6orf132 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | GALM | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | TEX29 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
mRNA | PRICKLE4 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | FIGLA | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
mRNA | MAP4K1 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-06 |
mRNA | ADD2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | IL26 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |